Intrinsic Value of S&P & Nasdaq Contact Us

Sugi Holdings Co.,Ltd. SGIPF OTC

Other OTC • Healthcare • Medical - Pharmaceuticals • JP • USD

SharesGrow Score
80/100
4/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Sugi Holdings Co.,Ltd. (SGIPF) generated $36.94B in operating cash flow for fiscal year 2025. After capital expenditures of $26.04B, free cash flow was $10.91B.

Free cash flow margin was 1.2% of revenue. Cash conversion ratio was 0.97x, suggesting some earnings are non-cash.

The company returned $5.13B in dividends and $1M in share buybacks to shareholders during the period.

Criteria supported by this page:

  • HEALTH (83/100, Pass) — demonstrate the company can comfortably service its debt
  • MOAT (64/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
  • INCOME (30/100) — Cash conversion ratio was 0.97x suggests some earnings are non-cash items

Overall SharesGrow Score: 77/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
80/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
→ Valuation
FUTURE
N/A
No coverage
PAST
100/100
→ Income
HEALTH
83/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
64/100
Proven by this page
GROWTH
100/100
→ Income
INCOME
30/100
→ Income
Sugi Holdings Co.,Ltd. Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $0.00$36.94B$39.04B$280.89M$62.39M
Capital Expenditure $0.00$-26.04B$-32.7B$-157.86M$-203.3M
Free Cash Flow $0.00$10.91B$6.34B$123.04M$-140.92M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message